Trial · NCT00799578

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

NCT00799578, Phase 1, Phase 2, Completed, Joel Lavine; results first posted 2014-01-31

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH). Trials, record NCT00799578. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00799578

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)
NCT number: NCT00799578
Status: Completed
Phases: Phase 1, Phase 2
Enrollment: 13 participants, actual
Lead sponsor: Joel Lavine
Conditions: Fatty Liver
Interventions: Cysteamine
First posted: 2008-12-01
Last updated: 2014-01-31
Results first posted: 2014-01-31

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Normalization or >50% of Serum ALT Levels From Baseline	6 months

Source ClinicalTrials.gov

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Normalization or >50% of Serum ALT Levels From Baseline	6 months		participants	NUMBER

Source ClinicalTrials.gov

Results by group1

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units
Normalization or >50% of Serum ALT Levels From Baseline	Number of Improved Subjects		7		participants

Source ClinicalTrials.gov

Participant flow3

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	Cystagon-EC	13
Overall Study	COMPLETED	Cystagon-EC	11
Overall Study	NOT COMPLETED	Cystagon-EC	2

Source ClinicalTrials.gov

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals3

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Number of Improved Subjects
Total, other adverse events	Number of Improved Subjects	0	13
Total, serious adverse events	Number of Improved Subjects	0	13

Source ClinicalTrials.gov

Papers16

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
638489	BACKGROUND	PubMed
1026552	BACKGROUND	PubMed
4116795	BACKGROUND	PubMed
4417718	BACKGROUND	PubMed
6347057	BACKGROUND	PubMed
10792033	BACKGROUND	PubMed
10842748	BACKGROUND	PubMed
11756758	BACKGROUND	PubMed
11933009	BACKGROUND	PubMed
12000605	BACKGROUND	PubMed

1 to 10 of 16

See all 16 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00799578

GET https://conductscience.org/api/trials/v1/NCT00799578/registered

API reference For AI assistants